-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Wl/6ITiXh2rcLtnxbjBhL9NJ2IW2SIhai+eVb4ywU1VDlh1WYVy4YP/c5fknhlZI qooCn2S215RQIZFfvr6pYQ== 0000950133-05-000557.txt : 20050214 0000950133-05-000557.hdr.sgml : 20050214 20050214171518 ACCESSION NUMBER: 0000950133-05-000557 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20050214 DATE AS OF CHANGE: 20050214 GROUP MEMBERS: VENROCK ASSOCIATES II, L.P. GROUP MEMBERS: VENROCK ENTREPRENEURS FUND, L.P. SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: MEMORY PHARMACEUTICALS CORP CENTRAL INDEX KEY: 0001062216 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-80464 FILM NUMBER: 05612354 BUSINESS ADDRESS: STREET 1: 100 PHILIPS PARKWAY CITY: MONTVALE STATE: NJ ZIP: 07645 BUSINESS PHONE: 2018027100 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: VENROCK ASSOCIATES CENTRAL INDEX KEY: 0000937889 IRS NUMBER: 136300995 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: ROOM 5508 STREET 2: 30 ROCKEFELLER PLAZA CITY: NEW YORK STATE: NY ZIP: 10112 BUSINESS PHONE: 2126495600 MAIL ADDRESS: STREET 1: ROOM 5508 STREET 2: 30 ROCKEFELLER PLAZA CITY: NEW YORK STATE: NY ZIP: 10112 SC 13G 1 w05800asc13g.htm SCHEDULE 13G sc13g
 

OMB APPROVAL
OMB Number: 3235-0145
Expires: December 31, 2005
Estimated average burden
hours per response...11


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

Under the Securities Exchange Act of 1934
(Amendment No. )*

Memory Pharmaceuticals Corp.

(Name of Issuer)

Common Stock

(Title of Class of Securities)

58606R403

(CUSIP Number)

December 31, 2004

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

        o Rule 13d-1 (b)

        o Rule 13d-1 (c)

        þ Rule 13d-1 (d)

*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the notes).

 

 

             
13G
CUSIP No. 58606R403 Page 2 of 8
  1. Name of Reporting Person:
Venrock Associates - I.R.S. #13-6300995		 I.R.S. Identification Nos. of above persons (entities only):
  2. Check the Appropriate Box if a Member of a Group:
    (a) þ1  
    (b) o  
  3. SEC Use Only:
  4. Citizenship or Place of Organization:
New York, United States
Number of
Shares
Beneficially
Owned by
Each Reporting
Person With
5. Sole Voting Power:
0
6. Shared Voting Power:
1,297,1572
7. Sole Dispositive Power:
0
8.Shared Dispositive Power:
1,297,1572
  9.Aggregate Amount Beneficially Owned by Each Reporting Person:
1,297,1572
  10.Check if the Aggregate Amount in Row (9) Excludes Certain Shares:
o
  11.Percent of Class Represented by Amount in Row (9):
6.3%
  12.Type of Reporting Person:
PN

     1 Venrock Associates, Venrock Associates II, L.P. and Venrock Entrepreneurs Fund, L.P. are members of a group for purposes of this Schedule 13G.

     2 Consists of 535,523 shares of common stock owned by Venrock Associates, 747,401 shares of common stock owned by Venrock Associates II, L.P. and 14,233 shares of common stock owned by Venrock Entrepreneurs Fund, L.P.

2

 

             
13G
CUSIP No. 58606R403 Page 3 of 8
  1. Name of Reporting Person:
Venrock Associates II, L.P. - I.R.S. #13-3844754		 I.R.S. Identification Nos. of above persons (entities only):
  2. Check the Appropriate Box if a Member of a Group:
    (a) þ1  
    (b) o  
  3. SEC Use Only:
  4. Citizenship or Place of Organization:
New York, United States
Number of
Shares
Beneficially
Owned by
Each Reporting
Person With
5. Sole Voting Power:
0
6. Shared Voting Power:
1,297,1572
7. Sole Dispositive Power:
0
8.Shared Dispositive Power:
1,297,1572
  9.Aggregate Amount Beneficially Owned by Each Reporting Person:
1,297,1572
  10.Check if the Aggregate Amount in Row (9) Excludes Certain Shares:
o
  11.Percent of Class Represented by Amount in Row (9):
6.3%
  12.Type of Reporting Person:
PN

     1 Venrock Associates, Venrock Associates II, L.P. and Venrock Entrepreneurs Fund, L.P. are members of a group for purposes of this Schedule 13G.

     2 Consists of 535,523 shares of common stock owned by Venrock Associates, 747,401 shares of common stock owned by Venrock Associates II, L.P. and 14,233 shares of common stock owned by Venrock Entrepreneurs Fund, L.P.

3

 

             
13G
CUSIP No. 58606R403 Page 4 of 8
  1. Name of Reporting Person:
Venrock Entrepreneurs Fund, L.P. -
I.R.S. #13-4078492		 I.R.S. Identification Nos. of above persons (entities only):
  2. Check the Appropriate Box if a Member of a Group:
    (a) þ1  
    (b) o  
  3. SEC Use Only:
  4. Citizenship or Place of Organization:
New York, United States
Number of
Shares
Beneficially
Owned by
Each Reporting
Person With
5. Sole Voting Power:
0
6. Shared Voting Power:
1,297,1572
7. Sole Dispositive Power:
0
8.Shared Dispositive Power:
1,297,1572
  9.Aggregate Amount Beneficially Owned by Each Reporting Person:
1,297,5172
  10.Check if the Aggregate Amount in Row (9) Excludes Certain Shares:
o
  11.Percent of Class Represented by Amount in Row (9):
6.3%
  12.Type of Reporting Person:
PN

     1 Venrock Associates, Venrock Associates II, L.P. and Venrock Entrepreneurs Fund, L.P. are members of a group for purposes of this Schedule 13G.

     2 Consists of 535,523 shares of common stock owned by Venrock Associates, 747,401 shares of common stock owned by Venrock Associates II, L.P. and 14,233 shares of common stock owned by Venrock Entrepreneurs Fund, L.P.

4

 

 
CUSIP No. 58606R403   13 G    

     Introductory Note: This Statement on Schedule 13G is filed on behalf of Venrock Associates, a limited partnership organized under the laws of the State of New York (“Venrock”), Venrock Associates II, L.P., a limited partnership organized under the laws of the State of New York (“Venrock II”), and Venrock Entrepreneurs Fund, L.P., a limited partnership organized under the laws of the State of New York (“Entrepreneurs Fund” and collectively with Venrock and Venrock II, the “Venrock Entities”) in respect of shares of Common Stock of Memory Pharmaceuticals Corp.

     
Item 1(a)
  Name of Issuer
 
    
  Memory Pharmaceuticals Corp.
 
    
Item 1(b)
  Address of Issuer’s Principal Executive Offices
 
    
  100 Philips Parkway
Montvale, New Jersey 07645
 
    
Item 2(a)
  Name of Person Filing
 
    
  Venrock Associates
Venrock Associates II, L.P.
Venrock Entrepreneurs Fund, L.P.
 
    
Item 2(b)
  Address of Principal Business Office or, if none, Residence
 
    
             
 
  New York Office:   Menlo Park Office:   Cambridge Office:
 
           
  30 Rockefeller Plaza   2494 Sand Hill Road   One Canal Park
  Room 5508   Suite 200   Suite 1120
  New York, NY 10112   Menlo Park, CA 94025   Cambridge, MA 02142
     
Item 2(c)
  Citizenship
 
    
  Each of Venrock, Venrock II and Entrepreneurs Fund are limited partnerships organized in the State of New York.
 
    
Item 2(d)
  Title of Class of Securities
 
    
  Common Stock
 
    
Item 2(e)
  CUSIP Number
 
    
  58606R403
 
    
Item 3
  Not applicable.

Page 5 of 8 Pages

 

 
CUSIP No. 58606R403   13 G    
     
Item 4
  Ownership
 
    
  (a) and (b)
 
    
  Venrock beneficially owns 535,523 shares of common stock, or 2.6% of the outstanding shares of common stock. Venrock II beneficially owns 747,401 shares of common stock, or 3.6% of the outstanding shares of common stock. Entrepreneurs Fund beneficially owns 14,233 shares of common stock, or 0.1% of the outstanding shares of common stock. Collectively, the Venrock Entities beneficially own an aggregate of 1,297,157 shares of common stock, or 6.3% of the outstanding shares of common stock.
 
    
  (c)
 
    
  Each of the Venrock Entities has sole power to dispose or to direct the disposition of no shares of the common stock, shared power to vote or to direct the vote of 1,297,157 shares of the common stock and shared power to dispose or to direct the disposition of 1,297,157 shares of the common stock.
 
    
Item 5
  Ownership of Five Percent or Less of a Class
 
    
  If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following ¨.
 
    
Item 6
  Ownership of More than Five Percent of Another Person
 
    
  Not applicable.
 
    
Item 7
  Identification and Classification of the Subsidiary which Acquired the Security Being Reported on by the Parent Holding Company
 
    
  Not applicable.
 
    
Item 8
  Identification and Classification of Members of the Group
 
    
  This schedule is being filed pursuant to Rule 13d-1(d). The identities of each of the Venrock Entities are stated in Item 2.
 
    
Item 9
  Notice of Dissolution of Group
 
    
  Not applicable.
 
    
Item 10
  Certification
 
    
  Not applicable.

Page 6 of 8 Pages

 

 
CUSIP No. 58606R403   13 G    

SIGNATURE

     After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this Statement is true, complete and correct.
         
February 14, 2005  VENROCK ASSOCIATES
 		  
  By:   /s/ Anthony Sun    
    Anthony Sun   
    Managing General Partner   
 
February 14, 2005  VENROCK ASSOCIATES II, L.P.
 		  
  By:   /s/ Anthony Sun    
    Anthony Sun   
    Managing General Partner   
 
February 14, 2005  VENROCK ENTREPRENEURS FUND, L.P.
 		  
  By:   /s/ Anthony Sun    
    Anthony Sun   
    Managing General Partner   

Page 7 of 8 Pages

 

         
 
CUSIP No. 58606R403   13 G    

EXHIBIT INDEX

     
Exhibit No.    
99.1
  Agreement pursuant to 13d-1(k)(1) among Venrock Associates, Venrock Associates II, L.P., and Venrock Entrepreneurs Fund, L.P.

Page 8 of 8 Pages

EX-99.1 2 w05800aexv99w1.htm EXHIBIT 99.1 exv99w1
 

CUSIP No. 58606R403   13 G    

Exhibit 99.1

AGREEMENT

     Pursuant to Rule 13d-1(k)(1) promulgated pursuant to the Securities Exchange Act of 1934, as amended, the undersigned agree that the attached Schedule 13G is being filed on behalf of each of the undersigned.
         
February 14, 2005  VENROCK ASSOCIATES
 		  
  By:   /s/ Anthony Sun    
    Anthony Sun   
    Managing General Partner   
 
February 14, 2005  VENROCK ASSOCIATES II, L.P.
 		  
  By:   /s/ Anthony Sun    
    Anthony Sun   
    Managing General Partner   
 
February 14, 2005  VENROCK ENTREPRENEURS FUND, L.P.
 		  
  By:   /s/ Anthony Sun    
    Anthony Sun   
    Managing General Partner   
 

 

-----END PRIVACY-ENHANCED MESSAGE-----